A new study has found that for some patients with treatment-resistant prostate cancer, a new treatment can “block" the messages cancer uses to “hijack" white blood cells.
I was diagnosed with prostate cancer about a year ago. Yes, it was bad news but one year later there's good news to share, too. I'm humbled by what's happened to me in the past year.
Florida medical tech company ArteraAI developed the ArteraAI Prostate Test, called the "first-ever predictive test" for patients with localized prostate cancer. Fox News Digital spoke to its CEO.
/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced that the University Hospitals (UH) Seidman Cancer Center in Cleveland has selected a MRIdian.
AI-Derived Digital Pathology-Based Biomarker To Predict the Benefit of ADT in Localized Prostate Cancer – Dan Spratt urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.